Tongue force and timing deficits in a rat model of Parkinson disease

Behavioural Brain Research

Volumn 222, Issue 2, 2011, Pages 315-320

  Ciucci, Michelle R ^a,b   Russell, John A ^a,b   Schaser, Allison J ^a,b   Doll, Emerald J ^a,b   Vinney, Lisa M ^a,b   Connor, Nadine P ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Department of Communicative Disorders ^*  (United States)

Author keywords

6 Hydroxydopamine; Dopamine; Dysphagia; Parkinson disease; Rat; Tongue deficits

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYKINESIA; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HYPOKINESIA; MALE; MEDIAL FOREBRAIN BUNDLE; MUSCLE FORCE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REWARD; TONGUE;

ANIMALS; BASAL GANGLIA; DEGLUTITION DISORDERS; DISEASE MODELS, ANIMAL; MALE; MEDIAL FOREBRAIN BUNDLE; MICROINJECTIONS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, INBRED F344; TIME FACTORS; TONGUE; TYROSINE 3-MONOOXYGENASE;

EID: 79955959562     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.03.057     Document Type: Article

References (46)

1. Ali G.N., Wallace K.L., Schwartz R., DeCarle D.J., Zagami A.S., Cook I.J. Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease. Gastroenterology 1996, 110:383-392.
2. Anstrom K.K., Schallert T., Woodlee M.T., Shattuck A., Roberts D.C. Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease. Behavioural Brain Research 2007, 179:183-191.
3. Bergman H., Deuschl G. Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Movement Disorders 2002, 17(Suppl 3):S28-S40.
4. Bird M.R., Woodward M.C., Gibson E.M., Phyland D.J., Fonda D. Asymptomatic swallowing disorders in elderly patients with Parkinson's disease: a description of findings on clinical examination and videofluoroscopy in 16 patients. Age and Ageing 1994, 23:251-254.
5. Braak H., Ghebremedhin E., Rüb U., Bratzke H., Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell and Tissue Research 2004, 318:121-134.
6. Braak H., Rüb U., Gai W.P., Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. Journal of Neural Transmission 2003, 110:517-536.
7. Ciucci M.R., Ahrens A.M., Ma S.T., Kane J.R., Windham E.B., Woodlee M.T., et al. Reduction of dopamine synaptic activity: degradation of 50kHZ ultrasonic vocalization in rats. Behavioral Neuroscience 2009, 123:328-336.
8. Ciucci M.R., Connor N.P. Dopaminergic influence on rat tongue function and limb movement initiation. Experimental Brain Research 2009, 194:587-596.
9. Ciucci M.R., Ma S.T., Fox C., Kane J.R., Ramig L.O., Schallert T. Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study. Behavioural Brain Research 2007, 182:284-289.
10. Ciucci M.R., Ma S.T., Kane J.R., Ahrens A.M., Schallert T. Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training. Parkinsonism and Related Disorders 2008, 14(Suppl 2):S172-S175.
11. Cohen A.D., Tillerson J.L., Smith A.D., Schallert T., Zigmond M.J. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. Journal of Neurochemistry 2003, 85:299-305.
12. Connor N.P., Russell J.A., Wang H., Jackson M.A., Mann L., Kluender K. Effect of tongue exercise on protrusive force and muscle fiber area in aging rats. Journal of Speech, Language, and Hearing Research 2009, 52:732-744.
13. Das S., Fowler S.C. An update of Fowler and Das: anticholinergic reversal of haloperidol-induced, within-session decrements in rats' lapping behavior. Pharmacology Biochemistry and Behavior 1996, 53:853-855.
14. Ertekin C., Tarlaci S., Aydogdu I., Kiylioglu N., Yuceyar N., Turman A.B., et al. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease. Movement Disorders 2002, 17:942-949.
15. Fleming S.M., Delville Y., Schallert T. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate. Behavioural Brain Research 2005, 156:201-213.
16. Foley P., Riederer P. Pathogenesis and preclinical course of Parkinson's disease. Journal of Neural Transmission Supplementum 1999, 56:31-74.
17. Fowler S.C., Das S. Haloperidol-induced decrements in force and duration of rats' tongue movements during licking are attenuated by concomitant anticholinergic treatment. Pharmacology Biochemistry and Behavior 1994, 49:813-817.
18. Fowler S.C., Mortell C. Low doses of haloperidol interfere with rat tongue extensions during licking: a quantitative analysis. Behavioral Neuroscience 1992, 106:386-395.
19. Fowler S.C., Wang G. Chronic haloperidol produces a time- and dose-related slowing of lick rhythm in rats: implications for rodent models of tardive dyskinesia and neuroleptic-induced parkinsonism. Psychopharmacology 1998, 137:50-60.
20. Fuh J.L., Lee R.C., Wang S.J., Lin C.H., Wang P.N., Chiang J.H., et al. Swallowing difficulty in Parkinson's disease. Clinical Neurology and Neurosurgery 1997, 99:106-112.
21. Fulceri F., Biagioni F., Lenzi P., Falleni A., Gesi M., Ruggieri S., et al. Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures. Annals of New York Academy of Science 2006, 1074:344-348.
22. Herrera-Marschitz M., Casas M., Ungerstedt U. Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses. Psychopharmacology 1988, 94:38-45.
23. Johnson A.M., Ciucci M.R., Russell J.A., Hammer M.J., Connor N.P. Ultrasonic output from the excised rat larynx. Journal of the Acoustical Society of America 2010, 128:EL75-EL79.
24. Leopold N.A., Kagel M.C. Pharyngo-esophageal dysphagia in Parkinson's disease. Dysphagia 1997, 12:11-18. discussion 19.
25. Marshall J.F. Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: spontaneous recovery and pharmacological control. Brain Research 1979, 177:311-324.
26. Miller N., Noble E., Jones D., Burn D. Hard to swallow: dysphagia in Parkinson's disease. Age and Ageing 2006, 35:614-618.
27. Monte F.S., da Silva-Júnior F.P., Braga-Neto P., Nobre e Souza M.A., de Bruin V.M. Swallowing abnormalities and dyskinesia in Parkinson's disease. Movement Disorders 2005, 20:457-462.
28. Moss S.J., Birkestrand B., Fowler S.C. The neuroimmunophilin GPI-1046 partially protects against 3-acetylpyridine toxicity in the rat. Neuroscience Letters 2002, 321:53-56.
29. Moss S.J., Wang G., Chen R., Pal R., Fowler S.C. 3-acetylpyridine reduces tongue protrusion force but does not abolish lick rhythm in the rat. Brain Research 2001, 920:1-9.
30. Nagaya M., Kachi T., Yamada T. Effect of swallowing training on swallowing disorders in Parkinson's disease. Scandinavian Journal of Rehabilitation Medicine 2000, 32:11-15.
31. Nagaya M., Kachi T., Yamada T., Igata A. Videofluorographic study of swallowing in Parkinson's disease. Dysphagia 1998, 13:95-100.
32. Petzinger G.M., Fisher B.E., Van Leeuwen J.E., Vukovic M., Akopian G., Meshul C.K., et al. Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease. Movement Disorders 2010, 25(Suppl 1):S141-S145.
33. Plowman-Prine E.K., Sapienza C.M., Okun M.S., Pollock S.L., Jacobson C., Wu S.S., et al. The relationship between quality of life and swallowing in Parkinson's disease. Movement Disorders 2009, 24:1352-1358.
34. Potulska A., Friedman A., Królicki L., Spychala A. Swallowing disorders in Parkinson's disease. Parkinsonism and Related Disorders 2003, 9:349-353.
35. Przuntek H., Müller T., Riederer P. Diagnostic staging of Parkinson's disease: conceptual aspects. Journal of Neural Transmission 2004, 111:201-216.
36. Robbins J.A., Logemann J.A., Kirshner H.S. Swallowing and speech production in Parkinson's disease. Annals of Neurology 1986, 19:283-287.
37. Rommelfanger K.S., Edwards G.L., Freeman K.G., Liles L.C., Miller G.W., Weinshenker D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:13804-13809.
38. Rommelfanger K.S., Weinshenker D., Norepinephrine: The redheaded stepchild of Parkinson's disease. Biochemistry and Pharmacology 2007, 74:177-190.
39. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000, 39:777-787.
40. Skitek E.B., Fowler S.C., Tessel R.E. Effects of unilateral striatal dopamine depletion on tongue force and rhythm during licking in rats. Behavioral Neuroscience 1999, 113:567-573.
41. Smittkamp S.E., Brown J.W., Stanford J.A. Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice. Neuroscience 2008, 151:613-621.
42. Tillerson J.L., Cohen A.D., Philhower J., Miller G.W., Zigmond M.J., Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. Journal of Neuroscience 2001, 21:4427-4435.
43. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiologica Scandinavica Supplementum 1971, 367:49-68.
44. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Research 1970, 24:485-493.
45. VanLeeuwen J.E., Petzinger G.M., Walsh J.P., Akopian G.K., Vuckovic M., Jakowec M.W. Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Journal of Neuroscience Research 2010, 88:650-668.
46. Woodlee M.T., Schallert T. The interplay between behavior and neurodegeneration in rat models of Parkinson's disease and stroke. Restorative Neurology and Neuroscience 2004, 22:153-161.